Tysabri (natalizumab) is a prescription drug that’s used to treat multiple sclerosis (MS), clinically isolated syndrome (CIS), and Crohn’s disease. Tysabri comes as an intravenous (IV) infusion (an ...
Pharmaceutical Technology on MSN
Biogen’s Tysabri to be used on England’s NHS for highly active MS
NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple sclerosis.
Tysabri (natalizumab) is a prescription drug used for multiple sclerosis (MS), clinically isolated syndrome (CIS), and Crohn’s disease. Tysabri can cause side effects that range from mild to serious.
ROCKVILLE, Md., Aug. 25, 2008--FDA ALERT [8/2008]: The FDA has recently received information from the manufacturer about two new cases of progressive multifocal leukoencephalopathy (PML) in patients ...
Verywell Health on MSN
A guide to multiple sclerosis medications
Medically reviewed by Lindsay Cook, PharmD Key Takeaways MS medications can help slow the disease and manage symptoms.
TYSABRI is a well-established high-efficacy treatment that now provides two routes of administration enabling flexibility to meet patients' individual preferences and needs The subcutaneous option ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback